Narrow by location

DOT Changes Drug Testing List

Safety

The U.S. Department of Transportation (DOT) recently issued a final rule that expands the DOT’s current drug testing panel to include some semi-synthetic opioids:

  • Hydrocodon – Trade names Norco, Vicodin, Lortab, Vicoprofen and Riboxen
  • Hydromorphone – Trade name Dilasudid
  • Oxymorphone – Trade name Numorphan
  • Oxycodone – Trade name Eucodal

DOT-regulated employers will be required to test for these highly abused opioids beginning on Jan. 1, 2018.

This change was made to enhance safety, prevent opioid abuse and combat the growing opioid epidemic in the United States. Currently, the DOT requires drug testing of safety-sensitive employees in the transportation industries.

“The opioid crisis is a threat to public safety when it involves safety-sensitive employees involved in the operation of any kind of vehicle or transport,” said Secretary Elaine L. Chao. “The ability to test for a broader range of opioids will advance transportation safety significantly and provide another deterrence to opioid abuse, which will better protect the public and ultimately save lives.”

 

One More Step Toward Agressive Enforcement of OSHA’s Construction Silica Standard

From Fisher Phillips Workplace Safety and Health Law Blog OSHA Publishes New Construction Industry Silica Frequently Asked Questions... »

Riding the Storm Out—A Reminder on Employer Issues During Bad Weather

By John W. Hargrove, Bradley When everyone’s phone issues that loooong beep indicating a hazardous weather warning or... »

Concussions Aren’t Just a Risk for NFL Players: Hardhats Versus Safety Helmets

From Fisher Phillips Workplace Safety and Health Law Blog While recently meeting with a group of contractors, I... »

Redefine Safety as the Elimination of Hazards

By Michael Barnes, Construction Executive When it comes to safety on a construction site, everyone has a role... »

LEAVE YOUR COMMENT

Your email address will not be published. Required fields are marked *